Consortium Member of the Month

Our consortium member of the month for the month of June goes to Clinical Research Coordinator Trenton Jarzomkowske from Atrium Health Wake Forest Baptist!

Trenton Jarzomkowske

We are proud to highlight Trenton’s exceptional work, a valued member of our research team at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Since joining us two years ago, Trenton has played a key role in supporting both the MPN-RC group and the hematologic malignancy research team in Winston Salem, NC. As part of a six-member team, he helps manage the clinical and administrative operations of more than 120 active trials, contributing to every phase from initiation to execution. Beyond his core responsibilities, Trenton is known for his reliability and team spirit—always ready to lend a hand to colleagues when needed. His calm demeanor and unique sense of humor bring a refreshing energy to the workplace. Trenton’s dedication to excellence and his passion for advancing cancer research are evident in everything he does. We are grateful for his contributions and proud to have him as part of our team.

Written by: Stacey Gentry Lewis (Oncology Research Nurse Manager - AHWFB)

Trenton, thank you so much for all of the phenomenal work you have done for the consortium.

Keep up the great work!

Title: DNMT3A mutations are unlikely to affect interferon-alpha treatment outcomes in polycythemia vera patients

Author(s): Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Yara Ganom, Christoph Klade, Kurt Krejcy, Heinz Gisslinger, Richard T Silver, Joseph Michael Scandura

MPN-RC Monthly Publication

We are HIRING!

Job Title: Clinical Research Coordinator I

Institution: Mount Sinai Health System

APPLY HERE!

*After applying for the position, please email your resume to Research Program Director Claire Borron at claire.borron@mssm.edu*

MPN-RC Updates: ASH Conference 2024

  • ASH Conference 2024

    (Left to Right: Susan Geyer, Carolyn Mead-Harvey, and Dr. Amylou Dueck) The Mayo Clinic group from the MPN Research Consortium attended the American Society of Hematology 2024 Conference in San Diego, California from December 7th - 10th.

  • ASH Conference 2024

    Dr. Shivani Handa presents her ASH abstract “243 TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms”. View the abstract here!

  • ASH Conference 2024

    Dr. Anna Rita Migliaccio asking after the talk at the plenary session on megakaryocytes in the elderly whether the GATA1low megakaryocytes which are enriched in the elderly represent an enrichment in the immune-megakaryocte subpopulations. 

  • Bridget Kelly Marcellino, MD,PhD

    873 Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells

    Full ASH Abstract

  • Shivani Handa, MD

    243 TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

    Full ASH Abstract